Pharmacologic management of patients with both heart failure and diabetes

MacDonald, M.R., Petrie, M.C., Fisher, M. and McMurray, J.J.V. (2009) Pharmacologic management of patients with both heart failure and diabetes. Current Heart Failure Reports, 6(2), pp. 126-132. (doi: 10.1007/s11897-009-0019-3)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1007/s11897-009-0019-3

Abstract

Diabetes and heart failure often occur together in patients, with each condition influencing the treatment of the other. Each disease has its own well-documented impact on prognosis, but when they are present in the same patient, the risk of morbidity and mortality increases substantially. Some therapies used in the treatment of diabetes are contraindicated in patients with heart failure, and some therapies for treating heart failure are often mistakenly believed to be contraindicated in patients with diabetes. This article aims to clarify the evidence behind treating these conditions simultaneously and dispel the myths surrounding the pharmacologic management of diabetes in heart failure and vice versa

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Petrie, Professor Mark and McMurray, Professor John
Authors: MacDonald, M.R., Petrie, M.C., Fisher, M., and McMurray, J.J.V.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
Journal Name:Current Heart Failure Reports
ISSN:1546-9530

University Staff: Request a correction | Enlighten Editors: Update this record